2012 Aarkstore.com | iBio, Inc. – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
iBio, Inc. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “iBio, Inc. - Product Pipeline Review
- 2012” provides data on the iBio, Inc.’s research and development focus. The report
includes information on current developmental pipeline, complete with latest
updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, iBio, Inc.’s corporate website, SEC filings, investor
presentations and featured press releases, both from iBio, Inc. and industry-specific
third party sources, put together by Global Markets Direct’s team.
Scope
- iBio, Inc. - Brief iBio, Inc. overview including business description, key information
and facts, and its locations and subsidiaries.
- Review of current pipeline of iBio, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 5

2. List of Figures 5
iBio, Inc. Snapshot 6
iBio, Inc. Overview 6
Key Information 6
Key Facts 6
iBio, Inc. – Research and Development Overview 7
Key Therapeutic Areas 7
iBio, Inc. – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
iBio, Inc. – Pipeline Products Glance 12
iBio, Inc. Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
iBio, Inc. – Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
iBio, Inc. – Drug Profiles 14
Alpha-1 Antitrypsin 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Anthrax Monoclonal Antibody 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Anthrax Vaccine 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
C1-Esterase Inhibitor 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Growth Factor 18
Product Description 18
Mechanism of Action 18

3. R&D Progress 18
H1N1 Influenza Vaccine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
H5N1 Avian Influenza Vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
HPV Vaccine 23
Product Description 23
Mechanism of Action 23
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Genta Incorporated – Product Pipeline Review – 2012
Geron Corporation – Product Pipeline Review – 2012
Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012

4. iBio, Inc. – Product Pipeline Review – 2012
ImmunoGen, Inc. – Product Pipeline Review – 2012
Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012
Celtic Biotech, Ltd. – Product Pipeline Review – 2012
Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012
Endocyte, Inc. – Product Pipeline Review – 2012
Flamel Technologies S.A. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com